Abstract
This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.
| Original language | English |
|---|---|
| Article number | e211610 |
| Journal | BMJ Case Reports |
| Volume | 11 |
| Issue number | 1 |
| Early online date | 28 Nov 2018 |
| DOIs | |
| Publication status | Published - Nov 2018 |
Fingerprint
Keywords
- Achromobacter denitrificans
- Aged
- Anti-Bacterial Agents/administration & dosage
- Bronchiectasis/drug therapy
- Gram-Negative Bacterial Infections/drug therapy
- Humans
- Male
Cite this
Achromobacter xylosoxidans in idiopathic cystic bronchiectasis. / Bates, Anthony Simon (Corresponding Author); Natarajan, Manjula; Reddy, Raja Vongala.
In: BMJ Case Reports, Vol. 11, No. 1, e211610, 11.2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Achromobacter xylosoxidans in idiopathic cystic bronchiectasis
AU - Bates, Anthony Simon
AU - Natarajan, Manjula
AU - Reddy, Raja Vongala
N1 - © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2018/11
Y1 - 2018/11
N2 - This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.
AB - This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.
KW - Achromobacter denitrificans
KW - Aged
KW - Anti-Bacterial Agents/administration & dosage
KW - Bronchiectasis/drug therapy
KW - Gram-Negative Bacterial Infections/drug therapy
KW - Humans
KW - Male
U2 - 10.1136/bcr-2015-211610
DO - 10.1136/bcr-2015-211610
M3 - Article
VL - 11
JO - BMJ Case Reports
JF - BMJ Case Reports
SN - 1757-790X
IS - 1
M1 - e211610
ER -